Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR00064
|
|||||
| Drug Name |
Indacaterol
|
|||||
| Synonyms |
5-(2-(5,6-Diethylindan-2-ylamino)-1-hydroxyethyl)-8-hydroxy-1H-quinolin-2-one; 5-[(1R)-2-[(5,6-diethyl-2,3-dihydro-1H-inden-2-yl)amino]-1-hydroxyethyl]-8-hydroxy-1H-quinolin-2-one; Indacaterol (USAN/INN); QAB-149
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Indication | Chronic obstructive pulmonary disease [ICD11: CA22] | Approved | [1] | |||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C24H28N2O3
|
|||||
| Canonical SMILES |
CCC1=C(C=C2CC(CC2=C1)NCC(C3=C4C=CC(=O)NC4=C(C=C3)O)O)CC
|
|||||
| InChI |
InChI=1S/C24H28N2O3/c1-3-14-9-16-11-18(12-17(16)10-15(14)4-2)25-13-22(28)19-5-7-21(27)24-20(19)6-8-23(29)26-24/h5-10,18,22,25,27-28H,3-4,11-13H2,1-2H3,(H,26,29)/t22-/m0/s1
|
|||||
| InChIKey |
QZZUEBNBZAPZLX-QFIPXVFZSA-N
|
|||||
| CAS Number |
CAS 312753-06-3
|
|||||
| Pharmaceutical Properties | Molecular Weight | 392.5 | Topological Polar Surface Area | 81.6 | ||
| Heavy Atom Count | 29 | Rotatable Bond Count | 6 | |||
| Hydrogen Bond Donor Count | 4 | Hydrogen Bond Acceptor Count | 4 | |||
| XLogP |
3.3
|
|||||
| PubChem CID | ||||||
| PubChem SID |
103751149
, 104152520
, 114788160
, 126665799
, 134339311
, 135252041
, 136946521
, 137248550
, 137261964
, 140383548
, 144116077
, 14805326
, 15126362
, 152258566
, 152343993
, 160645865
, 160647401
, 162011653
, 162197410
, 164227489
, 164777215
, 17194957
, 172919100
, 174528841
, 175266645
, 175426936
, 187051758
, 189561508
, 198991946
, 223601296
, 223667503
, 223701040
, 224342928
, 226432041
, 241382349
, 246478537
, 247088325
, 251916861
, 251918100
, 252063646
, 252110200
, 252436254
, 43529924
, 50944939
, 96025998
|
|||||
| ChEBI ID |
ChEBI:68575
|
|||||
| TTD Drug ID | ||||||
| DT(s) Transporting This Drug | OCT-1 | Transporter Info | Organic cation transporter 1 | Substrate | [2] | |
| P-GP | Transporter Info | P-glycoprotein 1 | Substrate | [3] | ||
| References | ||||||
| 1 | Indacaterol was approved by FDA. The official website of the U.S. Food and Drug Administration. (2019) | |||||
| 2 | Identification of novel substrates and structure-activity relationship of cellular uptake mediated by human organic cation transporters 1 and 2. J Med Chem. 2013 Sep 26;56(18):7232-42. | |||||
| 3 | KEGG: new perspectives on genomes, pathways, diseases and drugs. Nucleic Acids Res. 2017 Jan 4;45(D1):D353-D361. (dg:DG01665) | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.